bluebird bio (BLUE) Posts Wider Q2 Loss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. AAPL
3. PLTR
4. LITE
5. REGN
6. ABBV
7. MRVL
8. CL
9. CHKP
10. LYB

Go back to bluebird bio (BLUE) Posts Wider Q2 Loss

bluebird bio Reports Second Quarter 2015 Financial Results and Recent Operational Progress

August 6, 2015 4:06 PM EDT

-- Presented promising new beta-thalassemia major and severe sickle cell disease data from HGB-205 study at EHA annual meeting --

-- Announced global regulatory strategy for LentiGlobin BB305 in beta-thalassemia major, with plans to pursue conditional and accelerated registration strategies in the E.U. and U.S., respectively --

-- Announced broad T cell oncology strategy and related collaborations --

-- Hired Philip Gregory, D. Phil., as Chief Scientific Officer --

-- Completed successful public offering of common stock, raising net proceeds of $477.2... More